HB 591 proposes creating a new "Paid Family Leave Insurance Act" in Louisiana, allowing insurers to offer voluntary wage replacement coverage for employees taking time off for specific family reasons. The bill would enable employers or employees to purchase insurance policies covering up to 12 weeks of paid leave annually for qualifying events like a new child’s birth/adoption, caring for a family member with a serious health condition, or addressing military-related exigencies. Key provisions require policies to specify minimum benefit amounts (at least two weeks of coverage within 52 weeks), define eligibility, and detail how benefits are calculated based on wages. This legislation, currently pending in the Louisiana legislature, would establish a state-regulated insurance framework but does not mandate employer coverage or create a state-run program.
HB 807 establishes a special fund within Louisiana's state treasury to support the Community and Technical College System's workforce training programs. It directly affects community colleges and private-sector employers in high-demand industries like healthcare, manufacturing, and information technology by providing funding to hire more instructors and expand training capacity. Key provisions include using the fund for rapid-response instructor deployment, recruitment incentives, temporary instructors, and salary supplements - while prohibiting these funds from replacing existing state higher education funding. The program requires annual reporting to legislative committees on fund usage, supported industries, and credentials awarded.
HB 761 creates an advisory board within Louisiana's Department of Health to review and recommend new treatments for rare cancers. The 17-member board includes health officials, cancer researchers, oncologists from major institutions (like LSU, Tulane, and Xavier), and representatives from cancer research centers. The board must hold quarterly public meetings, compile findings within 30-45 days, and submit written reports to the Insurance Committees of both legislative chambers. This process directly affects how the Department of Health evaluates rare cancer treatments, streamlining recommendations to the agency for potential adoption.
HB 895 requires Louisiana hospitals and healthcare providers to offer sexual assault survivors specific medical treatments without undue delay. It mandates that providers make emergency contraception available and provide at least a three-day supply of HIV/STI prevention medication when medically needed, alongside private examinations adapted to each survivor's needs. The bill also requires hospitals to offer a survivor advocate (with confidential communications) during forensic exams, with the survivor's consent. This directly affects sexual assault survivors receiving emergency medical care in Louisiana hospitals.
HB 291 prevents health insurers in Louisiana from penalizing hospitals or clinics (participating healthcare facilities) solely because another provider at that facility - like a doctor or specialist - is dropped from the insurer's network. The bill directly affects healthcare facilities that coordinate patient care with multiple providers, ensuring they won’t face payment cuts or contract terminations due to a partner provider’s network status. Key provisions ban insurers from reducing payments or ending agreements with facilities based on another provider’s network exclusion, and require that any contract clauses attempting to override this rule are void. This policy change aims to stabilize provider relationships and care continuity for patients.
HB 766 requires health insurers in Louisiana to cover orally administered anti-cancer medications on the same terms as intravenously administered ones. It prohibits insurers from imposing higher copays, deductibles, or prior authorizations for oral medications compared to IV treatments, and bans programs that ignore drug discounts (like "accumulator" programs). The bill caps out-of-pocket costs for oral anti-cancer drugs at $100 per prescription and ensures cost-sharing counts toward annual out-of-pocket maximums. It applies to most health plans but excludes limited-benefit policies, high-deductible plans with HSAs, and self-funded ERISA plans. This directly affects cancer patients and insurers by reducing financial barriers to oral medication access.
HB 1247 establishes a statewide Sexual Assault Nurse Examiner Coordinator to oversee and support forensic care for sexual assault survivors across the state. The bill directly affects healthcare providers, law enforcement agencies, and survivors by creating a centralized role to improve the consistency and quality of medical examinations and evidence collection. Key provisions include defining the coordinator's responsibilities, setting up a funding mechanism, and outlining procedures for training and certification of Sexual Assault Nurse Examiners. The legislation aims to streamline the response to sexual assaults by ensuring survivors receive standardized, trauma-informed care from qualified professionals.
HB 1235 requires health insurance plans to cover prosthetic and custom orthotic devices and services based on medical necessity, as determined by the insured's doctors and specialists. The bill mandates that coverage levels must at least match federal standards for the elderly and disabled, while also prohibiting blanket exclusions for items used in physical activities or daily hygiene. Additionally, the legislation establishes specific appeal processes for denied claims and outlines detailed factors insurers must consider when evaluating medical necessity, such as the patient's current condition and functional needs.
HB 740 creates an independent review process for Medicaid claims related to the Coordinated System of Care (CSoC) program in Louisiana. It directly affects behavioral health providers and families enrolled in CSoC, which serves youth with significant behavioral health challenges who are in or at risk of out-of-home placement. The bill establishes that claims denials for CSoC services must undergo review by an independent third party, rather than being handled under the standard Medicaid managed care process. This change ensures CSoC-specific claims get specialized review, addressing gaps in the current system for this vulnerable population.
This bill directs the Louisiana Department of Health to conduct a study identifying gaps in acute healthcare access for individuals with intellectual and developmental disabilities. The legislation also establishes a committee to oversee this study, which will include representatives from the House and Senate, as well as one member appointed by the Senate president. The primary goal is to gather data on where and how these individuals face barriers in receiving timely medical care. Once the study is complete, the department is required to submit a report detailing its findings to the legislature.
